GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Cyclically Adjusted Price-to-FCF

Intelgenx Technologies (FRA:0IL) Cyclically Adjusted Price-to-FCF : (As of Jun. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Intelgenx Technologies Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Intelgenx Technologies's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Cyclically Adjusted Price-to-FCF Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Intelgenx Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Intelgenx Technologies's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Intelgenx Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelgenx Technologies's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's Cyclically Adjusted Price-to-FCF falls into.



Intelgenx Technologies Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Intelgenx Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Intelgenx Technologies's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.015/126.2576*126.2576
=-0.015

Current CPI (Mar. 2024) = 126.2576.

Intelgenx Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.008 99.473 -0.010
201409 -0.007 99.394 -0.009
201412 0.002 98.367 0.003
201503 -0.010 99.789 -0.013
201506 -0.017 100.500 -0.021
201509 -0.003 100.421 -0.004
201512 -0.009 99.947 -0.011
201603 -0.019 101.054 -0.024
201606 -0.030 102.002 -0.037
201609 0.052 101.765 0.065
201612 -0.020 101.449 -0.025
201703 -0.011 102.634 -0.014
201706 -0.023 103.029 -0.028
201709 -0.013 103.345 -0.016
201712 -0.024 103.345 -0.029
201803 -0.032 105.004 -0.038
201806 -0.019 105.557 -0.023
201809 -0.031 105.636 -0.037
201812 -0.028 105.399 -0.034
201903 -0.023 106.979 -0.027
201906 -0.023 107.690 -0.027
201909 -0.016 107.611 -0.019
201912 -0.021 107.769 -0.025
202003 -0.020 107.927 -0.023
202006 -0.013 108.401 -0.015
202009 -0.012 108.164 -0.014
202012 -0.004 108.559 -0.005
202103 -0.011 110.298 -0.013
202106 -0.012 111.720 -0.014
202109 -0.010 112.905 -0.011
202112 -0.012 113.774 -0.013
202203 -0.014 117.646 -0.015
202206 -0.016 120.806 -0.017
202209 -0.013 120.648 -0.014
202212 -0.014 120.964 -0.015
202303 -0.012 122.702 -0.012
202306 -0.012 124.203 -0.012
202309 -0.008 125.230 -0.008
202312 -0.003 125.072 -0.003
202403 -0.015 126.258 -0.015

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Intelgenx Technologies  (FRA:0IL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Intelgenx Technologies Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies (FRA:0IL) Business Description

Traded in Other Exchanges
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines